Palisade Bio Inc.宣布,其药物Pali-2108在临床试验中展现出良好的安全性特征,未出现任何严重不良事件、实验室检查异常或心电图相关问题。
Palisade Bio Inc.宣布,其药物Pali-2108在临床试验中展现出良好的安全性特征,未出现任何严重不良事件、实验室检查异常或心电图相关问题。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.